menu close
mammoth.bio

Mammoth Biosciences Stock

Company Profile:

Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Founded in 2017 by notable figures including Nobel laureate Jennifer Doudna, the company aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.

Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock
Buy + Sell

Mammoth Biosciences Funding

Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Apr 22, 2024 Series D 106.69M
Price
Valuation
Aug 05, 2021 Series D 150.00M
Price
Valuation
May 19, 2020 Series C 49.25M
Price
Valuation
May 19, 2020 Series C 747.77K
Price
Valuation
Feb 24, 2020 Series B 36.77M
Price
Valuation
Feb 24, 2020 Series B 7.41M
Price
Valuation
Feb 25, 2019 Series A 4.94M
Price
Valuation
May 15, 2018 Series A 13.16M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Mammoth Biosciences Management Team

  • Co-Founder, CEO, Director

    Trevor Martin

  • Director

    Maneesh Jain

  • Co-founder, Chief Science Officer

    Lucas Harrington

  • Co-founder, Chair of Scientific Advisory Board

    Jennifer A. Doudna

  • Co-Founder, Chief Technology Officer, Director

    Janice Chen

  • Director

    Min Cui

  • Director

    Jeff Huber

  • Director

    Jeremy Green

Mammoth Biosciences Major Investors

  • Verily Life Sciences LLC

  • Redmile Group

  • Decheng Capital LLC

  • Greenspring Associates, Inc

  • Greenspring Associates, Inc

  • Foresite Capital

  • Senator Investment Group

  • 8VC

  • Plum Alley Co.

  • Sixth Street Partners

  • Mayfield Fund

  • Pacific 8 Ventures

  • aMoon Fund

  • NFX

Learn More About Mammoth Biosciences Stock

Buy Mammoth Biosciences Stock
01
Mammoth Biosciences stock does not trade on public stock exchanges. Mammoth Biosciences stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Mammoth Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Mammoth Biosciences Stock
02
Mammoth Biosciences Stock does not trade on public stock exchanges. In order to sell Mammoth Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Mammoth Biosciences Stock Price
03
Mammoth Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Mammoth Biosciences share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Mammoth Biosciences Stock Ticker Symbol
04
There is no ticker symbol for Mammoth Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Mammoth Biosciences Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mammoth Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Mammoth Biosciences Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Mammoth Biosciences stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Mammoth Biosciences Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Mammoth Biosciences IPO
08
Mammoth Biosciences is a private company and has not had an IPO. There is currently no Mammoth Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Mammoth Biosciences IPO.
Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock
Buy + Sell

Other Companies

Clubhouse

A social audio app that allows users to engage in live conversations in virtual rooms.

Upside

Helps people get more value from their purchases and improves businesses' profitability while benefiting the world by offsetting carbon and food waste.

MX

Offers online software for financial management, debt elimination, and money-saving opportunities.

Route

Platform offering consumers and brands improved purchase tracking and protection.

Beyond Limits

Hybrid artificial intelligence company combining generative AI and machine learning with knowledge-based reasoning.

Movable

Provides agile email marketing strategies through their platform, allowing clients to create more dynamic and effective marketing campaigns.

Source: Nasdaq Private Market Tape D™